BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9604821)

  • 1. Patient management of cerebral origin spasticity with intrathecal baclofen.
    Rawlins P
    J Neurosci Nurs; 1998 Feb; 30(1):32-5, 40-6. PubMed ID: 9604821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
    Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
    J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal baclofen therapy and the child with cerebral palsy.
    Vitztum C; Olney B
    Orthop Nurs; 2000; 19(1):43-8. PubMed ID: 11062623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoliosis, spinal fusion, and intrathecal baclofen pump implantation.
    Scannell B; Yaszay B
    Phys Med Rehabil Clin N Am; 2015 Feb; 26(1):79-88. PubMed ID: 25479781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practices in intrathecal baclofen pump implantation in children with cerebral palsy in France.
    Mietton C; Nuti C; Dohin B; Bayle B; Fernandez B; Poirot I; Gautheron V; Vuillerot C
    Ann Phys Rehabil Med; 2016 Sep; 59(4):282-4. PubMed ID: 27158102
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients.
    Rawicki B
    J Neurosurg; 1999 Nov; 91(5):733-6. PubMed ID: 10541228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal baclofen therapy in children with cerebral palsy.
    Brown TR
    Arch Phys Med Rehabil; 2003 Apr; 84(4):624; author reply 624. PubMed ID: 12690609
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefit of enteral baclofen in the management of spasticity in cerebral palsy.
    Srinivasan R
    J Pediatr Rehabil Med; 2023; 16(1):19-24. PubMed ID: 36938745
    [No Abstract]   [Full Text] [Related]  

  • 9. Baclofen in the treatment of cerebral palsy.
    Albright AL
    J Child Neurol; 1996 Mar; 11(2):77-83. PubMed ID: 8881981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal baclofen therapy does not prevent hip displacement in children with cerebral palsy.
    Howard JJ; Shrader MW
    Dev Med Child Neurol; 2023 Aug; 65(8):1124. PubMed ID: 37208917
    [No Abstract]   [Full Text] [Related]  

  • 11. Spasticity in a child with myelomeningocele treated with continuous intrathecal baclofen.
    Bergenheim AT; Wendelius M; Shahidi S; Larsson E
    Pediatr Neurosurg; 2003 Oct; 39(4):218-21. PubMed ID: 12944705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
    Sampson FC; Hayward A; Evans G; Morton R; Collett B
    J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal baclofen in the management of spasticity due to cerebral palsy.
    Vloeberghs M; Keetley R; Morton R
    Pediatr Rehabil; 2005; 8(3):172-9. PubMed ID: 16087551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal baclofen in cerebral palsy movement disorders.
    Albright AL
    J Child Neurol; 1996 Nov; 11 Suppl 1():S29-35. PubMed ID: 8959459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life: effect of reduced spasticity from intrathecal baclofen.
    Gianino JM; York MM; Paice JA; Shott S
    J Neurosci Nurs; 1998 Feb; 30(1):47-54. PubMed ID: 9604822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.
    Van Schaeybroeck P; Nuttin B; Lagae L; Schrijvers E; Borghgraef C; Feys P
    Neurosurgery; 2000 Mar; 46(3):603-9; discussion 609-12. PubMed ID: 10719857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrathecal baclofen for children with chronic pain related to severe spasticity: advantages of tunneling the catheter in the testing phase].
    Gómez-Hoz T; Reinoso-Barbero F; de Vicente JC; Duran P; Campo G; Castro LE
    Rev Esp Anestesiol Reanim; 2005; 52(7):395-400. PubMed ID: 16200919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
    Baker KW; Tann B; Mutlu A; Gaebler-Spira D
    J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing spasticity in spinal cord injury: safe administration of bridge boluses during intrathecal baclofen pump refills.
    Elovic E; Kirshblum SC
    J Spinal Cord Med; 2003; 26(1):2-4. PubMed ID: 12830961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Title: Quantifying the change of spasticity after intrathecal baclofen administration: A descriptive retrospective analysis.
    Pittelkow TP; Bendel MA; Lueders DR; Beck LA; Pingree MJ; Hoelzer BC
    Clin Neurol Neurosurg; 2018 Aug; 171():163-167. PubMed ID: 29913361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.